Platform
Platform
-
LACOSTIM®- Overcome tumor microenvironment associated inhibitions
- Enhance T cell tumor killing and CAR-T cells persistence
- Orchestrate an adaptive immune response and enhance anti-tumor activity
-
Antibody- Fully human antibody discovery platform
- An industry-leading, high-quality library containing more than 100 billion antibodies
- T Cell Recognition Optimization Technology
-
Vector Platforms- GMP Lentivirus Vectors
- GMP RNA manufacture
- In Vivo CAR
-
Off-the-shelf- CRISPR Knock-In uCART
- RNA/LNP Cancer Vaccine
- In Vivo CAR
